| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443518 | European Journal of Cancer | 2014 | 8 Pages |
Abstract
This report confirms the therapeutic activity of sunitinib in EMC. Genotype/phenotype analyses support a correlation between response and EWSR1-NR4A3 fusion. Involvement of RET deserves further investigation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Stacchiotti, M.A. Pantaleo, A. Astolfi, G.P. Dagrada, T. Negri, A.P. Dei Tos, V. Indio, C. Morosi, A. Gronchi, C. Colombo, E. Conca, L. Toffolatti, M. Tazzari, F. Crippa, R. Maestro, S. Pilotti, P.G. Casali,